By Steven ReinbergHealthDay Reporter
THURSDAY, July 24, 2014 (HealthDay News) — An “unacceptably low” number of girls and boys are getting the human papillomavirus (HPV) vaccine, which protects against cervical, anal and other cancers, U.S. health officials said Thursday.
The U.S. Centers for Disease Control and Prevention recommends all boys and girls aged 11 and 12 get [...]
FRIDAY, July 18, 2014 (HealthDay News) — A new study involving data on more than 1 million women finds the HPV test outperforming the standard Pap test in assessing cervical cancer risk.
Researchers at the U.S. National Cancer Institute (NCI) conclude that a negative test for HPV (human papillomavirus) infection is associated with an extremely low [...]
By Kathleen DohenyHealthDay Reporter
TUESDAY, July 8, 2014 (HealthDay News) — Concerns that the human papillomavirus vaccine may increase the risk of serious blood clots seem unfounded, a new study says.
The study of half a million Danish women who received the HPV vaccine, which protects against cervical cancer and other health problems, found no link between [...]
MONDAY, June 2, 2014 (HealthDay News) — A new type of therapy shows promise in treating some women with advanced cervical cancer, researchers say.
The majority of cervical cancers are caused by the human papillomavirus (HPV). This new treatment — called HPV-targeted adoptive T cell therapy — boosts the body’s natural immune response to HPV in [...]
By Dennis ThompsonHealthDay Reporter
TUESDAY, April 29, 2014 (HealthDay News) — Romantic intimacy in long-term relationships often suffers when one partner gets a diagnosis of mouth or throat cancer caused by HPV, the sexually transmitted human papillomavirus. But new research suggests these couples can kiss as much and as deeply as they ever have, without worry.
MONDAY, April 14, 2014 (HealthDay News) — A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.
The high-risk HPV types 16 and 18 [...]
By Mary Brophy MarcusHealthDay Reporter
TUESDAY, March 4, 2014 (HealthDay News) — A new study offers more evidence that the human papillomavirus (HPV) vaccine is a powerful weapon in the fight against cervical cancer.
In a study that examined the vaccine’s effectiveness in a large population of Australian women, the University of Queensland researchers claim their finding [...]